Nuclear firm Newcleo pushes ahead with Nasdaq listing – despite €140m loss last year

Stefano Buono, CEO and co-founder of Newcleo. Press photo

Nuclear startup Newcleo is pushing ahead with its plans to list in New York, as regulatory filings show a €140m annual loss last year.

Become a member to continue reading